Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market sale 10% owner sold 44,417 shares at $4.20 ($186,600)
  2. 4 Open-market buy CEO, Chairman of the Board bought 5,000 shares at $4.22 ($21,095)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Shares withheld for taxes Chief Operating Officer gave up 452,587 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Operating Officer gave up 146,862 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Operating Officer gave up 355,282 shares (to pay taxes)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Shares withheld for taxes Director gave up 24,618 shares (to pay taxes)
  12. 4/A Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes Director gave up 24,618 shares (to pay taxes)
  17. 4 Other acquisition Chief Financial Officer acquired 5,228 shares (other)
  18. 4 Other acquisition Chief Operating Officer acquired 4,357 shares (other)
  19. 4 Option exercise Director acquired 32,811 shares (option exercise)
  20. 4 Shares withheld for taxes Director gave up 60,280 shares (to pay taxes)

Page 14 of 30 · 591 filings